Insulin pump vs. daily injections: pros, cons, and how to choose
If you’re managing diabetes, or have recently been diagnosed, you may be weighing your options between multiple daily injections (MDI) and an insulin pump. It’s completely normal to feel unsure. Both approaches can help you manage glucose levels, but they may fit into your day-to-day routine in different ways.
This guide will walk you through how each option works, what real life looks like using them, and how to decide with your HCP which approach may best support your needs, routine, and goals.
Insulin pumps vs. multiple daily injections
Both insulin pumps and injections are designed to deliver the insulin your body needs, but they do it in different ways.
What are multiple daily injections (MDI)?
Multiple daily injections involve taking insulin through a series of shots using an insulin pen or syringe. Most people use:
- A long‑acting insulin for background (basal) needs
- A rapid‑acting insulin for meals and corrections (bolus)
MDI requires careful timing, planning, and frequent glucose monitoring to guide dosing decisions.
What is an insulin pump?
An insulin pump is a device that delivers rapid-acting insulin throughout the day. Some pumps are worn on the body like a patch (tubeless), while others connect to the body through thin tubing. It replaces the need for separate long‑acting insulin by delivering:
- Continuous basal insulin in small amounts
- Bolus doses for meals or corrections
Insulin pumps can help reduce the number of injections because they are worn for multiple days.
What makes a tubeless pump different from tubed pumps?
Tubeless insulin pumps are worn directly on the body without tubing. Instead of connecting to a separate pump, insulin delivery happens through a wearable device. A separate device or app wirelessly communicates to the device to deliver insulin via a thin tube, called a cannula, which is inserted directly under the skin.
Tubeless insulin pumps can:
- Simplify wearability
- Remove tubing from daily activities
- Offer more flexibility for movement and clothing choices
Comparing glucose control
Both MDI and insulin pumps can achieve good glucose control when used consistently and correctly. However, differences emerge in how insulin is delivered and adjusted.
How MDI manages basal and bolus insulin
With multiple daily injections, insulin delivery requires planning and manual adjustments throughout the day:
- Basal insulin is fixed and lasts many hours
- Adjustments typically require planning ahead
- Bolus doses must be calculated and delivered manually
How insulin pumps deliver precise basal rates
Insulin pumps deliver insulin continuously and allow for real-time adjustments:
- Basal insulin is delivered in small, adjustable increments
- Delivery can be tailored throughout the day and night
How Automated Insulin Delivery (AID) adjusts insulin based on glucose levels
Some insulin pumps can connect with continuous glucose monitors (CGMs) to create an automated insulin delivery (AID) system, which uses real-time data to continuously adjust insulin in the background. This adds a layer of support beyond standard pump therapy by helping respond to glucose changes as they happen.
With an AID system:
- Insulin delivery is automatically adjusted based on CGM data
- The system can increase, decrease, or pause insulin to help reduce highs and lows
- Users still need to bolus for meals and enter carbohydrate amounts
By making small, ongoing adjustments, AID systems can help improve time in range and reduce the day‑to‑day burden of managing diabetes.1
Daily life using an insulin pump vs. multiple daily injections
Beyond the numbers, managing diabetes is about how treatment fits into your life. Small differences in how insulin is delivered can have a big impact on how flexible, predictable, and manageable life feels over time. The following are some examples of everyday scenarios in which people often notice differences between multiple daily injections and insulin pump therapy:
Injection frequency and needle fatigue
With MDI, multiple injections each day can feel physically and emotionally tiring over time. Some people experience “injection fatigue.” Pumps can help reduce needle fatigue because sites are typically changed every few days.
Sleep, night lows, and overnight management
Overnight control may be a challenge with MDI due to fixed basal insulin. Pump systems, especially automated ones, can adjust insulin delivery overnight, helping reduce lows.¹
Physical activity, sports, and swimming
MDI users may need to manually adjust insulin. Pump users can:
- Adjust basal rates
- Use activity settings (depending on the system)
- Pause insulin if needed
Tubeless options may offer even greater flexibility for movement and water activities (depending on whether or not the system is waterproof).
Lifestyle considerations for insulin pump vs. injections
Different lifestyles can shape which option feels more manageable. Daily routines, life stage, and activity levels can all influence which approach feels more realistic, comfortable, and sustainable over time. Here’s how different needs and life situations may shape that decision.
For active adults and athletes
Staying active can make insulin needs less predictable, especially with changes in intensity, duration, or timing of exercise. Some people prefer insulin pumps for their ability to adjust insulin delivery more frequently, while others find injections work well with established routines.
For children and teens
Managing diabetes during school, activities, and social situations can be complex for both children and their caregivers. Some families choose pumps to reduce the number of daily injections and allow for more flexible adjustments, while others prefer injections for their simplicity and familiarity.
For people recently diagnosed with type 1
At diagnosis, there’s often a lot to learn in a short period of time, and treatment plans may evolve over time. MDI is often the starting point, but pumps may be introduced later as comfort with diabetes management grows.
Common hesitations about switching to an insulin pump
It’s completely normal to have concerns when considering a change. Many people weigh the pros and cons carefully before deciding what feels right. If you’re feeling uncertain, you’re not alone.
I've been on injections for years. Is it worth changing?
Many people stay on MDI successfully, but others explore pumps for added flexibility, lifestyle preferences, more precise insulin delivery, or support with managing highs and lows.
I'm worried about wearing a device on my body.
This is one of the most common concerns. Tubeless options may help reduce visibility and discomfort for some users. Many people find that it takes a short adjustment period, but over time the device becomes part of their routine. Factors like placement options, clothing, and comfort can all play a role in how it feels day to day.
What if the technology fails?
Pump systems include safety features and alerts. You’ll also have backup plans, including insulin injections if needed. You can work with your healthcare provider to establish what your backup plan looks like.
Will it be too complicated to learn?
There is a learning curve, but most people receive training and support from healthcare teams and/or professionals who are trained and certified by a pump manufacturer.
What does switching from multiple daily injections look like?
Transitioning from MDI to a pump is a process, not an overnight change. It typically involves working with your diabetes care team to adjust insulin settings, learn how the device works, and build confidence using it in real-life situations. Some people move through this transition quickly, while others take more time to decide what feels right for their routine.
Work with your diabetes care team to evaluate options
Starting an insulin pump is a collaborative process, and your healthcare provider will help guide the transition based on your individual needs and goals.
Your provider will typically help determine:
- Your insulin needs
- Whether a pump is a good fit for your lifestyle
- A training and support plan to help you get started
Know what to expect in your first few weeks on a pump
The transition to a pump usually happens over time, with a period of learning and adjustment as you get familiar with how it works.
In the first few weeks, this often includes:
- Learning how to use the device and navigate its settings
- Adjusting insulin delivery to better match your body’s needs
- Monitoring glucose patterns more closely and making refinements
Real experience: one Podder's switch from MDI to Omnipod®
Many people describe initial hesitation when switching but also increased confidence over time. Check out this story from one of our Podders to learn about her experience making the switch and how she benefited.
MDI vs insulin pump: Which approach might be right for you?
Choosing between MDI and a pump is personal. It depends on your lifestyle, comfort with technology, and treatment goals.
To help guide your decision, consider the following questions:
- How comfortable am I with technology?
- Do I want more flexibility in my daily routine?
- How often do I experience highs or lows?
- How do I feel about injections vs. wearable devices?
- Do I have a fear of needles or injection fatigue?
Your healthcare provider can also help you determine which option may be the best fit for you. You can download this doctor discussion guide for helpful questions to bring to your next appointment.
Learn more about Omnipod® 5
The Omnipod 5 Automated Insulin Delivery System is a wearable, tubeless, and waterproof* pump that proactively helps to correct highs, protect from lows, and has been shown to lower A1C.2-4
Related Articles
Other topics
References and Disclaimers
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
1. American Diabetes Association. Standards of Care in Diabetes—2026.
https://diabetes.org
2. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Study funded by Insulet.
3. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 39.4% vs. 29.5%. Average time with low blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 3.43% vs. 2.46%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Study funded by Insulet.
4. Pasquel FJ, et al. Presented at: ADA; June 21-24, 2024; Orlando, FL. Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. Mean time >180 mg/dL as measured by CGM: ST = 54%, 3-mo Omnipod 5 = 34%, P<0.001. Mean time <70 mg/dL as measured by CGM: ST = 0.2%, 3-mo Omnipod 5 = 0.2%. Mean HbA1c: ST vs. 13-week Omnipod 5: 8.2% vs. 7.4%, P<0.001.
The Omnipod® 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Admelog®, and Kirsty®.
Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia. WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
Available products subject to current insurance coverage and product indication for use. Insulet can only support onboarding for those customers within the product indication.